Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VANI Vivani Medical, Inc.

Trading 07-08 13:56:47 EDT

1.55

+0.20

+14.44%

High1.58	Low1.33	Vol1.49M
Open1.36	D1 Closing1.35	Amplitude18.52%
Mkt Cap133.23M	Tradable Cap55.13M	Total Shares86.24M
T/O2.23M	T/O Rate4.18%	Tradable Shares35.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VANI","market":"US","secType":"STK","nameCN":"Vivani Medical, Inc.","latestPrice":1.545,"timestamp":1783533391237,"preClose":1.35,"halted":0,"volume":1492589,"delay":0,"changeRate":0.14444444444444432,"floatShares":35685603,"shares":86235104,"eps":-0.398941,"marketStatus":"Trading","change":0.195,"latestTime":"07-08 13:56:47 EDT","open":1.36,"high":1.58,"low":1.33,"amount":2231661.9066413,"amplitude":0.185185,"askPrice":1.55,"askSize":272,"bidPrice":1.54,"bidSize":424,"shortable":3,"etf":0,"ttmEps":-0.398941,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1783540800000},"marketStatusCode":2,"adr":0,"listingDate":1416373200000,"exchange":"NASDAQ","adjPreClose":1.35,"preHourTrading":{"tag":"盘前","latestPrice":1.36,"preClose":1.35,"latestTime":"09:27 EDT","volume":40782,"amount":54645.8979948,"timestamp":1783517260041,"change":0.01,"changeRate":0.007407,"amplitude":0.059259},"postHourTrading":{"tag":"盘后","latestPrice":1.37,"preClose":1.35,"latestTime":"19:59 EDT","volume":162766,"amount":216930.186,"timestamp":1783468748933,"change":0.02,"changeRate":0.014815,"amplitude":0.074074},"volumeRatio":0.818845,"impliedVol":1.9986,"impliedVolPercentile":0.8566},"requestUrl":"/m/hq/s/VANI/tweets","defaultTab":"tweets","newsList":[{"id":"2649954785","title":"Vivani Medical Signs Deal with Novo Nordisk to Evaluate Npm-139 Semaglutide Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2649954785","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649954785?lang=en_us&edition=fundamental","pubTime":"2026-07-08 11:12","pubTimestamp":1783480348,"startTime":"0","endTime":"0","summary":"Vivani Medical signs deal with Novo Nordisk to evaluate NPM-139 semaglutide implantVivani signed a new agreement allowing Novo Nordisk to run a non-exclusive internal evaluation of its NPM-139 semaglu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL4s96JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","SG9999014039.USD","VANI","LU0314104364.USD","SG9999014021.USD","BK4112","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","LU2095319765.USD","BK4082","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","SG9999014005.SGD","BCDF","SG9999014013.SGD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649932346","title":"Vivani Medical Publishes Investor Presentation on Nanoportal Long-acting GLP-1 Implant Pipeline for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2649932346","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649932346?lang=en_us&edition=fundamental","pubTime":"2026-07-08 02:49","pubTimestamp":1783450153,"startTime":"0","endTime":"0","summary":"Vivani Medical publishes investor presentation on NanoPortal long-acting GLP-1 implant pipeline for obesityVivani outlined its NanoPortal miniature drug-implant platform targeting ultra long-acting GL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL8LGTXy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","LU0158827781.USD","LU0795875086.SGD","LU2357305700.SGD","BK4082","LU0006306889.USD","LU1064131342.USD","LU0795875169.SGD","LU2089284900.SGD","LU0267386448.USD","LU2023251221.USD","LU1548497426.USD","LU2111349929.HKD","LU2133065610.SGD","LU1244550577.SGD","LU1732799900.SGD","LU0106831901.USD","IAI","LU1791710400.SGD","LU1791710582.SGD","LU1244550494.USD","LU1732800096.USD","LU0234570918.USD","KBWB","LU0098860793.USD","LU2028103732.USD","LU0557290698.USD","BK4581","LU0210528500.USD","LU1989772840.SGD","LU2264538146.SGD","LU0158827948.USD","LU0320765646.SGD","LU2271345857.HKD","LU0314104364.USD","LU1074936037.SGD","LU2487616109.SGD","VANI","BK4585","LU1720051017.SGD","IE00BKVL7J92.USD","LU0971096721.USD","BK4534","LU2347655156.SGD","LU0225283273.USD","IE00BZ1G4Q59.USD","LU0912757837.SGD","LU0053666078.USD","BK4516","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649198001","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2649198001","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649198001?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:02","pubTimestamp":1783429368,"startTime":"0","endTime":"0","summary":"Healthcare stocks were rising pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF  1.2% higher and the iShares Biotechnology ETF  up 1.1%.Vivani Medical  said Novo Nordisk  will conduct an internal evaluation of NPM-139, Vivani's semaglutide drug implant intended for chronic weight management, under a new agreement. Shares of Novo Nordisk were up more than 2% premarket.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","NVOX","PPH","BK4082","OZEM","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","THNR","BK4532","LU1093756168.USD","BK4588","BK4599","BK4581","LU0154236417.USD","LABU","IBB","XBI","BK4585","LU1093756325.SGD","BK4007","NVOH","XLV","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649898745","title":"Vivani Advances GLP-1 Implant Program With Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2649898745","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649898745?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:18","pubTimestamp":1783426687,"startTime":"0","endTime":"0","summary":"Vivani Medical ( ($VANI) ) just unveiled an announcement. On July 1, 2026, Vivani Medical entered into a definitive merger agreement under which it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vivani-advances-glp-1-implant-program-with-novo-nordisk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vivani-advances-glp-1-implant-program-with-novo-nordisk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0154236417.USD","NVO","BK4082","OZEM","BK4585","PPH","LU1093756325.SGD","LU1093756168.USD","NVOX","NVOH","THNR","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","VANI","BK4007","BK4532","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649873639","title":"Vivani Medical Jumps as Novo Nordisk Evaluates Weight-loss Drug Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2649873639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649873639?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:55","pubTimestamp":1783425314,"startTime":"0","endTime":"0","summary":"BUZZ-Vivani Medical jumps as Novo Nordisk evaluates weight-loss drug implant** Shares of Vivani MedicalVANI.Osoars 19% to $1.55 premarket** The biotech firm says it signed an agreement allowing Novo Nordisk to evaluate its experimental weight-loss drug implant** NPM-139 is designed to provide long-lasting delivery of obesity medicines through an implant, potentially reducing the need for frequent injections - VANI** The deal includes no exclusivity rights for Novo Nordisk** Co expects to begin an early-stage human study in mid-2026, comparing the implant with Novo Nordisk's Wegovy obesity injections** Study will assess safety and how the drug moves through the body, with the aim of advancing to a larger trial if results are positive** As of last close, stock was up ~6% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4390ZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984025","title":"Vivani Medical - to Initiate Phase 1 Study of Npm-139 Semaglutide Implant in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984025?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:35","pubTimestamp":1783424100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA995LZT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649840269","title":"Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate Npm-139, a Miniature, Ultra Long-acting Semaglutide Implant for Chronic Weight Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2649840269","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649840269?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:35","pubTimestamp":1783424100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA995LZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649044984","title":"Vivani Medical: no Exclusivity Provisions for Npm-139, or Vivani's Proprietary Nanoportal Technology Associated with Agreement with Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2649044984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649044984?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:35","pubTimestamp":1783424100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA995LZT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649671383","title":"Clearone Enters Merger Deal to Acquire Vivani Unit Cortigent","url":"https://stock-news.laohu8.com/highlight/detail?id=2649671383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649671383?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:33","pubTimestamp":1783369985,"startTime":"0","endTime":"0","summary":"ClearOne enters merger deal to acquire Vivani unit CortigentClearOne agreed to acquire Vivani Medical’s Cortigent unit via a merger, leaving Cortigent as a wholly owned subsidiary at closing.Vivani wi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL2CMQ9T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRO","CRGT","BK4082","VANI","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648166216","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2648166216","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648166216?lang=en_us&edition=fundamental","pubTime":"2026-07-04 00:20","pubTimestamp":1783095615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vivani Medical (VANI) and CVS Health (CVS) with bull...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-243?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-243?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","LU1983299246.USD","LU0211331839.USD","BK4585","LU0208291251.USD","LU0320765489.SGD","LU1923622614.USD","LU2433249047.HKD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","VANI","RTH","BK4196","LU0070302665.USD","LU0432979614.USD","CVS","LU1059921491.USD","BK4550","LU0162691827.USD","BK4504","LU2125909247.SGD","LU2125909593.SGD","BK4588","LU0006061336.USD","IE0002270589.USD","IHF","IE00B7SZLL34.SGD","BK4581","IE00BZ1G4Q59.USD","LU1699723380.USD","LU1571399168.USD","LU0072461881.USD","LU0061475181.USD","BK4082","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648868236","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2648868236","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648868236?lang=en_us&edition=fundamental","pubTime":"2026-07-03 01:35","pubTimestamp":1783013718,"startTime":"0","endTime":"0","summary":"StablecoinX  soared 57% amid heavy trading after the company introduced its flagship infrastructure software platform, StablecoinX Harness, it said Thursday.Intraday trading volume surged to over 45.1 million from a daily average of roughly 1.1 million.Vivani Medical  has signed a definitive agreement to merge its Cortigent subsidiary with a ClearOne  unit, it said Thursday.Shares of ClearOne surged 155% as intraday trading volume catapulted to over 60.6 million from a daily average of about 11,000.Bassett Furniture Industries  reported better-than-expected fiscal Q2 earnings and revenue late Wednesday.Shares rose 8% following an increase in intraday trading volume to over 161,000 from a daily average of about 50,000.Price: 3.26, Change: +1.18, Percent Change: +56.73","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4020","BK4082","BSET","VANI","BK4095","USDE","CLRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648020325","title":"ClearOne enters into merger agreement with Cortigent","url":"https://stock-news.laohu8.com/highlight/detail?id=2648020325","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648020325?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:05","pubTimestamp":1782993914,"startTime":"0","endTime":"0","summary":"ClearOne (CLRO) entered into a definitive agreement and plan of merger among its wholly-owned subsidiary, Vivani Medical (VANI), and Cortigent, a w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearone-enters-into-merger-agreement-with-cortigent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearone-enters-into-merger-agreement-with-cortigent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4020","BK4082","CRGT","VANI","CLRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648502293","title":"Clearone Set to Trade as Cortigent Holdings Under NASDAQ Ticker CRGT After Vivani Deal Closes","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502293","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648502293?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:03","pubTimestamp":1782993795,"startTime":"0","endTime":"0","summary":"ClearOne set to trade as Cortigent Holdings under Nasdaq ticker CRGT after Vivani deal closesClearOne entered a merger agreement that would rename it Cortigent Holdings and shift its Nasdaq ticker to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL1v55Sy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","CRGT","BK4082","CLRO","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648507856","title":"Clearone Enters Merger Deal to Acquire Vivani Unit Cortigent","url":"https://stock-news.laohu8.com/highlight/detail?id=2648507856","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648507856?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:01","pubTimestamp":1782993674,"startTime":"0","endTime":"0","summary":"ClearOne enters merger deal to acquire Vivani unit CortigentClearOne agreed to merge with Vivani Medical’s unit Cortigent, which will become a wholly owned subsidiary at closing.Vivani will receive 12","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL5tzTHb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4020","CRGT","VANI","BK4082","CLRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648502218","title":"Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed Clearone, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648502218?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:00","pubTimestamp":1782993602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUAF1WP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4020","VANI","BK4082","CLRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647553727","title":"Vivani Medical Wins Australia Ethics Approval to Start Phase 1 Slim-1 Trial of Semaglutide Implant Npm-139","url":"https://stock-news.laohu8.com/highlight/detail?id=2647553727","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647553727?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:05","pubTimestamp":1782821144,"startTime":"0","endTime":"0","summary":"Vivani Medical wins Australia ethics approval to start Phase 1 SLIM-1 trial of semaglutide implant NPM-139Vivani Medical won ethics clearance from Australia’s Bellberry HREC to start SLIM-1, a Phase 1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL8TZtPw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646354370","title":"Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of DR. Dean Baker","url":"https://stock-news.laohu8.com/highlight/detail?id=2646354370","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646354370?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:30","pubTimestamp":1782473400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUA68FKXV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4139","FDMT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646354395","title":"Press Release: Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker","url":"https://stock-news.laohu8.com/highlight/detail?id=2646354395","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646354395?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:30","pubTimestamp":1782473400,"startTime":"0","endTime":"0","summary":"ALAMEDA, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (\"Vivani\" or the \"Company\"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting d","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4099","BK4082","BK4588","BK4604","BK4555","TM","VANI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646877839","title":"Vivani Medical Wins Australia Ethics Approval to Launch Slim-1 Semaglutide Implant Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2646877839","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646877839?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:30","pubTimestamp":1782387047,"startTime":"0","endTime":"0","summary":"Vivani Medical wins Australia ethics approval to launch SLIM-1 semaglutide implant trialVivani Medical won ethics approval from Australia’s Bellberry HREC to start SLIM-1, a Phase 1 trial of its NPM-1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL7r9s9p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4585","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","VANI","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD","LU2210150020.SGD","BK4588","IE00BKPKM429.USD","LU0314104364.USD","NDAQ","LU2095319765.USD","SG9999014021.USD","LU2210149790.SGD","BK4082","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646187200","title":"Vivani Medical Receives Regulatory Approval for the Initiation of Slim-1, a Phase 1 Clinical Trial of Npm-139 Semaglutide Implant in Obesity and Chronic Weight Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2646187200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646187200?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:30","pubTimestamp":1782387000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUABXFX0X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivani.com;investors.vivani.com","stockEarnings":[{"period":"1week","weight":0.0887},{"period":"1month","weight":0.1441},{"period":"3month","weight":0.2736},{"period":"6month","weight":0.0305},{"period":"1year","weight":0.063},{"period":"ytd","weight":0.0976}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0138},{"period":"3month","weight":0.1061},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.2047},{"period":"ytd","weight":0.0965}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.013761},{"month":2,"riseRate":0.333333,"avgChangeRate":0.262607},{"month":3,"riseRate":0.333333,"avgChangeRate":0.172227},{"month":4,"riseRate":0.416667,"avgChangeRate":0.031848},{"month":5,"riseRate":0.5,"avgChangeRate":0.041822},{"month":6,"riseRate":0.416667,"avgChangeRate":-0.052506},{"month":7,"riseRate":0.5,"avgChangeRate":-0.013265},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.10962},{"month":9,"riseRate":0.636364,"avgChangeRate":-0.039438},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.074632},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.062683},{"month":12,"riseRate":0.333333,"avgChangeRate":0.011596}],"exchange":"NASDAQ","name":"Vivani Medical, Inc.","nameEN":"Vivani Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vivani Medical, Inc.(VANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vivani Medical, Inc.,VANI,Vivani Medical, Inc.股票,Vivani Medical, Inc.股票老虎,Vivani Medical, Inc.股票老虎国际,Vivani Medical, Inc.行情,Vivani Medical, Inc.股票行情,Vivani Medical, Inc.股价,Vivani Medical, Inc.股市,Vivani Medical, Inc.股票价格,Vivani Medical, Inc.股票交易,Vivani Medical, Inc.股票购买,Vivani Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vivani Medical, Inc.(VANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction